(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday voted in favor of Johnson & Johnson’s experimental nasal spray, which has a compound similar to often-abused ketamine, bringing the drug closer to approval. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike...
Post
Gaming system helps with autism diagnosis
Autism Spectrum Disorder (ASD) is a developmental condition that affects communication, social skills and other behaviours. Characteristic of some cases in both children and adults is repetitive movements or unusual behaviour – stereotyped movements. A research team from France and Morocco describe in the International Journal of Biomedical Engineering and Technology, an automated detection system...
Post
Noninvasive liquid biopsies rapidly, accurately determine response to cancer treatment
Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer treatment responses by measuring circulating tumor DNA (ctDNA) during immunotherapy and related treatments. Johns Hopkins Medicine “There is an unmet clinical need for real-time, noninvasive detection of tumor response to targeted and immune checkpoint blockade treatments,” says...
Post
San Diego neuroscientist says brain-buzzing device causes weight loss
A San Diego entrepreneur just took first place in a big startup competition put on by all the University of California schools, winning judges over with its brain-manipulating wearable device used for weight loss. Credit: CC0 Public Domain Neurovalens makes a headset (worn like headphones) that stimulates a region of the braintied to appetite. Wearing...
Post
Promise of stem cell technologies for treating Parkinson’s disease
Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD) in future. Writing in a special supplement to the Journal of Parkinson’s Disease, experts describe how newly developed stem cell technologies could be used to treat the disease and discuss the great promise, as well as the significant challenges,...
Post
New study shows more protein and fewer calories help older people lose weight safely
A high-protein, low-calorie diet helps older adults with obesity lose more weight, maintain more muscle mass, improve bone quality and lose “bad” fat, according to results from a new randomized controlled trial led by Wake Forest University researcher Kristen Beavers. Kristen Beavers. Credit: WFU / Ken Bennett Four research papers based on the study results...
Post
Here’s what you need to know about melioidosis, the deadly infection that can spread after floods – biological sciences
The devastating Townsville floods have receded but the clean up is being complicated by the appearance of a serious bacterial infection known as melioidosis. One person has died from melioidosis and nine others have been diagnosed with the disease over the past week. People typically become sick between one and 21 days after being infected....
Post
When research participation pays, some people lie, Penn study suggests
PHILADELPHIA – Offering compensation can be an important tactic to attract potential participants for enrollment in research studies, but it might come at a cost. A new study conducted by researchers in the Perelman School of Medicine at the University of Pennsylvania found that up to 23 percent of respondents lied about their eligibility to...
Post
Immersive virtual reality therapy shows lasting effect of treatment for autism phobias
Virtual reality has been shown to help children with autism with nearly 45% remaining free from their fears and phobias six months after treatment. Medical Xpress.com A separate study also published tomorrow, has shown for the first time that the treatment works for some autistic adults. The Blue Room, developed by specialists at Newcastle University...
Post
Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San...